New for Upcoming MedTech Conference: AdvaMed Announces Investor Forum, Including Session With Chief Executives for Corporate Purpose
WASHINGTON, May 17, 2022 /3BL Media/ - The Advanced Medical Technology Association (AdvaMed), the world’s largest trade organization representing medical technology device developers and manufacturers, today announced the first-ever Investor Forum at The MedTech Conference in October. The Investor Forum will feature special programs, including a flagship session called the Chief Executives for Corporate Purpose (CECP) CEO Investor Forum @ The MedTech Conference, where leading medtech CEOs will share insights on the sustained value of medtech for investors. Conference attendees will be able to attend regular programming, often relevant to investors, in addition to the investor-focused sessions.
“AdvaMed is always looking to increase value to our members and The MedTech Conference attendees,” said Scott Whitaker, AdvaMed president and CEO. “Expanding our investment programming at the conference makes sense in a lot of ways. Medtech companies range from the smallest startups to companies that are household names. Investment often plays a key role at every stage of development. On the investor side, medtech companies offer value for investors of all kinds. Our companies serve the core needs of society, with technology that saves and improves lives. Bringing medtech developers and investors together will help our industry create even more innovative products to serve patients.”
Investor Forum programming will include reverse pitch presentations featuring corporate and business development executives and investors; one-on-one partnering, where companies and investors will be able to evaluate fresh investment opportunities, from startups to emerging growth companies; sessions covering topics such as mergers and acquisitions, early- and growth-stage funding, the supply chain, and the latest on regulatory and reimbursement issues; presentations from the top 50 early and mid-stage companies in the 2022 MedTech Innovator program; and the day-long CECP’s CEO Investor Forum @ The MedTech Conference, where leading medtech CEOs will share their companies’ Long-Term Plans for sustainable value creation with investors. EY is a presenting sponsor of the CECP CEO Investor Forum @ The MedTech Conference.
“This 10th CEO Investor Forum, co-hosted by CECP and AdvaMed, will provide an opportunity for leading medtech companies to share their sustainable business long-term plans to those assembled and a global online audience,” said Daryl Brewster, CEO, Chief Executives for Corporate Purpose. “Companies will share their integrated plans. Investors will gain more insight about how companies drive long-term value. And, unlike so much investor communication, the focus will be on investing in and driving sustainable value creation across their stakeholders, not just short-term gains."
Development of the Investor Forum at The MedTech Conference is being guided by a committee of medtech industry leaders and investors.
“Medical device technology improves the quality of life for countless patients,” said Darshana Zaveri, founder and managing partner of Catalyst Health Ventures, who is participating in the Investor Forum committee. “As a Bostonian, I’m delighted The Medtech Conference will launch its new investor content in Boston. Our city has a tremendous medtech presence, from startups to established companies, and a positive environment for investors to learn more about the medtech products in development or already serving patients in Boston and beyond.”
Each fall, AdvaMed convenes The MedTech Conference as the foremost gathering of medical technology professionals in North America. The MedTech Conference this year takes place October 24-26 in person in Boston.
The MedTech Conference will include its traditional slate of world-class speakers and cross-cutting educational programming in addition to the Investor Forum. Register here.
CECP Media Contact:
Katie Leasor
kleasor@cecp.co
# # #
About AdvaMed
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures, and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.
About Chief Executives for Corporate Purpose (CECP)
Chief Executives for Corporate Purpose® (CECP) is a trusted advisor to companies on their corporate purpose journeys to build long-term sustainable value and tell their impact stories. CECP is a movement of more than 200 of the world’s largest companies that represent $11.2 trillion in revenues, $23 billion in total community investment, 14 million employees, 30 million hours of employee engagement, and $21 trillion in assets under management. For more information, visit http://cecp.co.
